Teva Pharmaceutical Industries (BSP:T1EV34) Other Long Term Assets : R$11,186 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Teva Pharmaceutical Industries Other Long Term Assets?

Teva Pharmaceutical Industries's other long-term assets for the quarter that ended in Dec. 2023 was R$11,186 Mil.

Teva Pharmaceutical Industries's quarterly other long-term assets increased from Jun. 2023 (R$9,809 Mil) to Sep. 2023 (R$10,989 Mil) and increased from Sep. 2023 (R$10,989 Mil) to Dec. 2023 (R$11,186 Mil).

Teva Pharmaceutical Industries's annual other long-term assets increased from Dec. 2021 (R$6,277 Mil) to Dec. 2022 (R$9,961 Mil) and increased from Dec. 2022 (R$9,961 Mil) to Dec. 2023 (R$11,186 Mil).

Teva Pharmaceutical Industries Other Long Term Assets Historical Data

The historical data trend for Teva Pharmaceutical Industries's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Other Long Term Assets Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

4,014.20

6,348.56

6,276.94

9,961.02

11,186.24

Teva Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															9,961.02	10,526.58	9,809.33	10,988.61	11,186.24

Teva Pharmaceutical Industries Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Teva Pharmaceutical Industries (BSP:T1EV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (BSP:T1EV34) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEVA:Austria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

Teva Pharmaceutical Industries (BSP:T1EV34) Headlines

No Headlines